• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

功能分离的人源抗体可快速诱导B细胞淋巴瘤细胞凋亡。

Rapid induction of apoptosis in B-cell lymphoma by functionally isolated human antibodies.

作者信息

Fransson Johan, Tornberg Ulla-Carin, Borrebaeck Carl A K, Carlsson Roland, Frendéus Björn

机构信息

Department of Immunotechnology, Lund University, Lund, Sweden.

出版信息

Int J Cancer. 2006 Jul 15;119(2):349-58. doi: 10.1002/ijc.21829.

DOI:10.1002/ijc.21829
PMID:16477633
Abstract

Novel panning and screening methodology was devised to isolate high affinity human recombinant scFv antibody fragments with functionally associated properties in B lymphoma cells. The approach was used to generate a panel of apoptosis-inducing antibodies specific for antigens differentially expressed in B lymphoma vs. T leukaemia cells. The selections resulted in an antibody pool with near perfect selectivity (>99%) for the B lymphoma target cells. Randomly picked clones (72) revealed 7 unique antibody genotypes. Six of these rapidly induced apoptosis in target cells. Following the conversion to full IgGs, the antibodies were shown to be specific for HLA-DR/DP, the B-cell receptor mu chain and for CD54/ICAM-1. The latter receptor was not previously associated with apoptotic properties in B-cell lymphomas. Anti-ICAM-1 IgG induced apoptosis in a broad range of B lymphoma cell lines and were shown by immunohistochemistry to bind strongly to B lymphoma tissue obtained from 5 different B lymphoma patients. The recombinant IgG antibodies had affinities in the subnanomolar (0.3 nM) to nanomolar (3 nM) range. The described technology is generally applicable for the rapid isolation of high affinity human antibodies with specificity for differentially expressed cell surface receptors with intrinsic negative or positive signalling properties from naïve phage libraries.

摘要

设计了新型淘选和筛选方法,以从B淋巴瘤细胞中分离出具有功能相关特性的高亲和力人重组单链抗体片段。该方法用于生成一组对B淋巴瘤细胞与T白血病细胞中差异表达的抗原具有特异性的凋亡诱导抗体。筛选结果产生了一个对B淋巴瘤靶细胞具有近乎完美选择性(>99%)的抗体库。随机挑选的克隆(72个)显示出7种独特的抗体基因型。其中六种能在靶细胞中迅速诱导凋亡。转化为完整的IgG后,这些抗体被证明对HLA-DR/DP、B细胞受体μ链和CD54/ICAM-1具有特异性。后一种受体以前未与B细胞淋巴瘤的凋亡特性相关联。抗ICAM-1 IgG在多种B淋巴瘤细胞系中诱导凋亡,并通过免疫组织化学显示与从5名不同B淋巴瘤患者获得的B淋巴瘤组织强烈结合。重组IgG抗体的亲和力在亚纳摩尔(0.3 nM)至纳摩尔(3 nM)范围内。所描述的技术通常适用于从原始噬菌体文库中快速分离对具有内在负或正信号特性的差异表达细胞表面受体具有特异性的高亲和力人抗体。

相似文献

1
Rapid induction of apoptosis in B-cell lymphoma by functionally isolated human antibodies.功能分离的人源抗体可快速诱导B细胞淋巴瘤细胞凋亡。
Int J Cancer. 2006 Jul 15;119(2):349-58. doi: 10.1002/ijc.21829.
2
Evaluating antibodies for their capacity to induce cell-mediated lysis of malignant B cells.评估抗体诱导恶性B细胞细胞介导裂解的能力。
Cancer Res. 1998 Jul 15;58(14):3051-8.
3
Loss of B7.2 (CD86) and intracellular adhesion molecule 1 (CD54) expression is associated with decreased tumor-infiltrating T lymphocytes in diffuse B-cell large-cell lymphoma.B7.2(CD86)和细胞间黏附分子1(CD54)表达缺失与弥漫性B细胞大细胞淋巴瘤中肿瘤浸润性T淋巴细胞减少相关。
Clin Cancer Res. 2000 Oct;6(10):3904-9.
4
TCR-independent killing of B cell malignancies by anti-third-party CTLs: the critical role of MHC-CD8 engagement.抗第三方 CTL 对 B 细胞恶性肿瘤的 TCR 非依赖性杀伤:MHC-CD8 结合的关键作用。
J Immunol. 2011 Aug 15;187(4):2006-14. doi: 10.4049/jimmunol.1100095. Epub 2011 Jul 13.
5
Monoclonal antibodies to HLA-DP, DQ, and DR determinants: functional effects on the activation and proliferation of normal and EBV-transformed B cells.针对HLA-DP、DQ和DR决定簇的单克隆抗体:对正常和EB病毒转化的B细胞激活和增殖的功能影响
Exp Hematol. 1986 Oct;14(9):887-95.
6
A recombinant bispecific single-chain fragment variable specific for HLA class II and Fc alpha RI (CD89) recruits polymorphonuclear neutrophils for efficient lysis of malignant B lymphoid cells.一种针对 HLA Ⅱ类和 FcαRI(CD89)的重组双特异性单链片段可变区,可募集多形核粒细胞,有效裂解恶性 B 淋巴细胞。
J Immunol. 2010 Feb 1;184(3):1210-7. doi: 10.4049/jimmunol.0902033. Epub 2009 Dec 30.
7
Effective lysis of lymphoma cells with a stabilised bispecific single-chain Fv antibody against CD19 and FcgammaRIII (CD16).用一种针对CD19和FcγRIII(CD16)的稳定双特异性单链Fv抗体有效裂解淋巴瘤细胞。
Br J Haematol. 2005 Jul;130(2):218-28. doi: 10.1111/j.1365-2141.2005.05414.x.
8
Fully human, HLA-DR-specific monoclonal antibodies efficiently induce programmed death of malignant lymphoid cells.完全人源化的HLA-DR特异性单克隆抗体可有效诱导恶性淋巴细胞的程序性死亡。
Nat Med. 2002 Aug;8(8):801-7. doi: 10.1038/nm736. Epub 2002 Jul 8.
9
The in vitro biological activity of the HLA-DR-binding clinical IgG4 antibody 1D09C3 is a consequence of the disruption of cell aggregates and can be abrogated by Fab arm exchange.HLA-DR结合临床IgG4抗体1D09C3的体外生物学活性是细胞聚集体破坏的结果,并且可以通过Fab臂交换消除。
Mol Immunol. 2009 Oct;46(16):3269-77. doi: 10.1016/j.molimm.2009.07.031. Epub 2009 Aug 21.
10
Enhancement of scFv fragment reactivity with target antigens in binding assays following mixing with anti-tag monoclonal antibodies.在与抗标签单克隆抗体混合后,结合测定中scFv片段与靶抗原反应性的增强。
J Immunol Methods. 2004 Nov;294(1-2):23-35. doi: 10.1016/j.jim.2004.08.005.

引用本文的文献

1
Deep Mining of Complex Antibody Phage Pools.深度挖掘复杂抗体噬菌体库。
Methods Mol Biol. 2023;2702:419-431. doi: 10.1007/978-1-0716-3381-6_22.
2
Sequence enrichment profiles enable target-agnostic antibody generation for a broad range of antigens.序列富集图谱可实现针对广泛抗原的无靶向抗体生成。
Cell Rep Methods. 2023 May 9;3(5):100475. doi: 10.1016/j.crmeth.2023.100475. eCollection 2023 May 22.
3
Concerted Antibody and Antigen Discovery by Differential Whole-cell Phage Display Selections and Multi-omic Target Deconvolution.
协同抗体和抗原发现的差示全细胞噬菌体展示选择和多组学目标分解。
J Mol Biol. 2023 May 15;435(10):168085. doi: 10.1016/j.jmb.2023.168085. Epub 2023 Apr 3.
4
Accelerating target deconvolution for therapeutic antibody candidates using highly parallelized genome editing.利用高度并行化的基因组编辑技术加速治疗性抗体候选物的靶标去卷积。
Nat Commun. 2021 Feb 24;12(1):1277. doi: 10.1038/s41467-021-21518-4.
5
Fc-engineering significantly improves the recruitment of immune effector cells by anti-ICAM-1 antibody MSH-TP15 for myeloma therapy.Fc 工程显著增强了抗细胞间黏附分子-1 抗体 MSH-TP15 募集免疫效应细胞用于多发性骨髓瘤治疗的效果。
Haematologica. 2021 Jul 1;106(7):1857-1866. doi: 10.3324/haematol.2020.251371.
6
Deep Mining of Complex Antibody Phage Pools Generated by Cell Panning Enables Discovery of Rare Antibodies Binding New Targets and Epitopes.通过细胞淘选产生的复杂抗体噬菌体库的深度挖掘有助于发现结合新靶点和表位的稀有抗体。
Front Pharmacol. 2019 Jul 30;10:847. doi: 10.3389/fphar.2019.00847. eCollection 2019.
7
Ligandomics: a paradigm shift in biological drug discovery.配体组学:生物药物发现的范式转变。
Drug Discov Today. 2018 Mar;23(3):636-643. doi: 10.1016/j.drudis.2018.01.013. Epub 2018 Jan 8.
8
A single-arm, open-label, phase 2 clinical trial evaluating disease response following treatment with BI-505, a human anti-intercellular adhesion molecule-1 monoclonal antibody, in patients with smoldering multiple myeloma.一项单臂、开放标签的2期临床试验,评估人抗细胞间黏附分子-1单克隆抗体BI-505治疗冒烟型多发性骨髓瘤患者后的疾病反应。
PLoS One. 2017 Feb 3;12(2):e0171205. doi: 10.1371/journal.pone.0171205. eCollection 2017.
9
Serum concentrations of apoptosis-associated molecules in septic children with leukemia, neutropenia and fever.
Int J Hematol. 2017 May;105(5):668-675. doi: 10.1007/s12185-016-2175-z. Epub 2017 Jan 31.
10
Function-first antibody discovery: Embracing the unpredictable biology of antibodies.功能优先的抗体发现:接纳抗体不可预测的生物学特性。
Oncoimmunology. 2013 Aug 1;2(8):e25047. doi: 10.4161/onci.25047. Epub 2013 May 20.